สมัครสมาชิก

เข้าสู่ระบบ

Lee’s Pharm participated in BIOHK2024, focusing on rare disease drug innovation

ข่าวสารอื่นๆ

New product “Nitric Oxide for Inhalation” (INOmax®) was approved for commercialization in China

เมษายน 22, 2022
New product “Nitric Oxide for Inhalation” (INOmax®) was approved for commercialization in China

The launch of the new production line at Zhaoke-Hefei manufacturing site

กรกฎาคม 3, 2025
The launch of the new production line at Zhaoke-Hefei manufacturing site

Lee’s Pharm in-house product Yallaferon® was honoured with “2021 Biopharmaceutical Excellent Brand” Award

ธันวาคม 29, 2021
Lee’s Pharm in-house product Yallaferon® was honoured with “2021 Biopharmaceutical Excellent Brand” Award

HKSTP InnoAcademy — Technology Leaders of Tomorrow programme

ตุลาคม 21, 2020
HKSTP InnoAcademy — Technology Leaders of Tomorrow programme

License Transfer from Solasia to Lee’s Pharm for the Sales Promotion of Sancuso® and episil® in three cities in China

มิถุนายน 30, 2022
License Transfer from Solasia to Lee’s Pharm for the Sales Promotion of Sancuso® and episil® in three cities in China

Zhaoke-Hefei was recognized as “2022 Excellent Enterprise of National Intellectual Property” by the China National Intellectual Property Administration

ตุลาคม 17, 2022
Zhaoke-Hefei was recognized as “2022 Excellent Enterprise of National Intellectual Property” by the China National Intellectual Property Administration
thThai
en_USEnglish thThai